MTOR and neoplasm: Among the pleiotropic downstream drivers of KRAS-driven oncogenesis, multiple studies have demonstrated the importance of the PI3K/AKT/mTOR cascade in promoting the immunosuppressive properties of PDAC lesions via effects on both tumor cells and other immune constituents within the TME (10).